Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator
Class II transactivator (CIITA) is necessary for expression of class II MHC (MHC-II) molecules. In mice, CIITA expression is regulated by three promoters (pI, pIII, and pIV), producing types I, III, and IV CIITA. The relative roles of different CIITA types remain unclear. Unstimulated bone marrow-de...
Gespeichert in:
Veröffentlicht in: | The Journal of immunology (1950) 2002-08, Vol.169 (3), p.1326-1333 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1333 |
---|---|
container_issue | 3 |
container_start_page | 1326 |
container_title | The Journal of immunology (1950) |
container_volume | 169 |
creator | Pai, Rish K Askew, David Boom, W. Henry Harding, Clifford V |
description | Class II transactivator (CIITA) is necessary for expression of class II MHC (MHC-II) molecules. In mice, CIITA expression is regulated by three promoters (pI, pIII, and pIV), producing types I, III, and IV CIITA. The relative roles of different CIITA types remain unclear. Unstimulated bone marrow-derived macrophages expressed low levels of CIITA mRNA; type I CIITA was nine times more abundant than type IV (type III CIITA was barely detected). Exposure to IFN-gamma (6 h) dramatically increased types I and IV CIITA mRNA to similar absolute levels. Type IV CIITA declined over time, but type I was stable for over 72 h. Thus, the dominant form of CIITA evolved with time during activation by IFN-gamma, and type I CIITA explained prolonged expression of MHC-II by macrophages. mRNA half-life was shorter for type I than type IV CIITA, suggesting that sustained transcription contributed to stable expression of type I CIITA induced by IFN-gamma. Splenic B cells expressed mRNA for type III CIITA but very little for types I or IV. Treatment with IL-4 increased surface expression of MHC-II protein, but mRNA for MHC-II and CIITA (total, I, III, and IV) remained unchanged, suggesting posttranslational regulation. Splenic dendritic cells expressed type I CIITA but little type III or IV; CpG DNA induced their maturation and decreased types I and III CIITA, consistent with decreased MHC-II protein synthesis. CIITA types differ in regulation in various APCs under different stimuli, and the predominant type of CIITA varies at different stages of APC activation. |
doi_str_mv | 10.4049/jimmunol.169.3.1326 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71932449</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71932449</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-926ed3cff834f180a614ee041a32a07afeb4198f2d409430f0541fbb01f2c1df3</originalsourceid><addsrcrecordid>eNpNkMFKw0AQhhdRbK0-gSA56cXUmd3NtvFWQrUBRZHqddkmuzaySepuYu3bm9KKXmYG5vv_w0fIOcKQA49vPoqybKvaDlHEQzZERsUB6WMUQSgEiEPSB6A0xJEY9ciJ9x8AIIDyY9JDiozFUdQn-Yt-b61qiroKahMkVnkfpGnwOEuC6ffKae-3r6IKJs-Jvw1eaqv9lpxvVt2RXndwN1SVB-nbX3zuVOVV1hRfqqndKTkyynp9tt8D8no3nSez8OHpPk0mD2HGOW_CmAqds8yYMeMGx6AEcq2Bo2JUwUgZveAYjw3NOcScgYGIo1ksAA3NMDdsQC53vStXf7baN7IsfKatVZWuWy9HGDPKedyBbAdmrvbeaSNXriiV20gEuZUrf-XKTq5kciu3S13s69tFqfO_zN5mB1ztgGXxvlwXTktfKms7HOV6vf5X9QNcjILk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71932449</pqid></control><display><type>article</type><title>Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Pai, Rish K ; Askew, David ; Boom, W. Henry ; Harding, Clifford V</creator><creatorcontrib>Pai, Rish K ; Askew, David ; Boom, W. Henry ; Harding, Clifford V</creatorcontrib><description>Class II transactivator (CIITA) is necessary for expression of class II MHC (MHC-II) molecules. In mice, CIITA expression is regulated by three promoters (pI, pIII, and pIV), producing types I, III, and IV CIITA. The relative roles of different CIITA types remain unclear. Unstimulated bone marrow-derived macrophages expressed low levels of CIITA mRNA; type I CIITA was nine times more abundant than type IV (type III CIITA was barely detected). Exposure to IFN-gamma (6 h) dramatically increased types I and IV CIITA mRNA to similar absolute levels. Type IV CIITA declined over time, but type I was stable for over 72 h. Thus, the dominant form of CIITA evolved with time during activation by IFN-gamma, and type I CIITA explained prolonged expression of MHC-II by macrophages. mRNA half-life was shorter for type I than type IV CIITA, suggesting that sustained transcription contributed to stable expression of type I CIITA induced by IFN-gamma. Splenic B cells expressed mRNA for type III CIITA but very little for types I or IV. Treatment with IL-4 increased surface expression of MHC-II protein, but mRNA for MHC-II and CIITA (total, I, III, and IV) remained unchanged, suggesting posttranslational regulation. Splenic dendritic cells expressed type I CIITA but little type III or IV; CpG DNA induced their maturation and decreased types I and III CIITA, consistent with decreased MHC-II protein synthesis. CIITA types differ in regulation in various APCs under different stimuli, and the predominant type of CIITA varies at different stages of APC activation.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.169.3.1326</identifier><identifier>PMID: 12133955</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>Animals ; Antigen-Presenting Cells - metabolism ; B-Lymphocytes - physiology ; Dendritic Cells - physiology ; Gene Expression Regulation ; Genes, MHC Class II ; Interferon-gamma - pharmacology ; Interleukin-4 - pharmacology ; Macrophages - metabolism ; Mice ; Mice, Inbred C3H ; Nuclear Proteins ; RNA Stability ; RNA, Messenger - genetics ; Trans-Activators - classification ; Trans-Activators - genetics ; Trans-Activators - physiology</subject><ispartof>The Journal of immunology (1950), 2002-08, Vol.169 (3), p.1326-1333</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-926ed3cff834f180a614ee041a32a07afeb4198f2d409430f0541fbb01f2c1df3</citedby><cites>FETCH-LOGICAL-c444t-926ed3cff834f180a614ee041a32a07afeb4198f2d409430f0541fbb01f2c1df3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12133955$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pai, Rish K</creatorcontrib><creatorcontrib>Askew, David</creatorcontrib><creatorcontrib>Boom, W. Henry</creatorcontrib><creatorcontrib>Harding, Clifford V</creatorcontrib><title>Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>Class II transactivator (CIITA) is necessary for expression of class II MHC (MHC-II) molecules. In mice, CIITA expression is regulated by three promoters (pI, pIII, and pIV), producing types I, III, and IV CIITA. The relative roles of different CIITA types remain unclear. Unstimulated bone marrow-derived macrophages expressed low levels of CIITA mRNA; type I CIITA was nine times more abundant than type IV (type III CIITA was barely detected). Exposure to IFN-gamma (6 h) dramatically increased types I and IV CIITA mRNA to similar absolute levels. Type IV CIITA declined over time, but type I was stable for over 72 h. Thus, the dominant form of CIITA evolved with time during activation by IFN-gamma, and type I CIITA explained prolonged expression of MHC-II by macrophages. mRNA half-life was shorter for type I than type IV CIITA, suggesting that sustained transcription contributed to stable expression of type I CIITA induced by IFN-gamma. Splenic B cells expressed mRNA for type III CIITA but very little for types I or IV. Treatment with IL-4 increased surface expression of MHC-II protein, but mRNA for MHC-II and CIITA (total, I, III, and IV) remained unchanged, suggesting posttranslational regulation. Splenic dendritic cells expressed type I CIITA but little type III or IV; CpG DNA induced their maturation and decreased types I and III CIITA, consistent with decreased MHC-II protein synthesis. CIITA types differ in regulation in various APCs under different stimuli, and the predominant type of CIITA varies at different stages of APC activation.</description><subject>Animals</subject><subject>Antigen-Presenting Cells - metabolism</subject><subject>B-Lymphocytes - physiology</subject><subject>Dendritic Cells - physiology</subject><subject>Gene Expression Regulation</subject><subject>Genes, MHC Class II</subject><subject>Interferon-gamma - pharmacology</subject><subject>Interleukin-4 - pharmacology</subject><subject>Macrophages - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C3H</subject><subject>Nuclear Proteins</subject><subject>RNA Stability</subject><subject>RNA, Messenger - genetics</subject><subject>Trans-Activators - classification</subject><subject>Trans-Activators - genetics</subject><subject>Trans-Activators - physiology</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkMFKw0AQhhdRbK0-gSA56cXUmd3NtvFWQrUBRZHqddkmuzaySepuYu3bm9KKXmYG5vv_w0fIOcKQA49vPoqybKvaDlHEQzZERsUB6WMUQSgEiEPSB6A0xJEY9ciJ9x8AIIDyY9JDiozFUdQn-Yt-b61qiroKahMkVnkfpGnwOEuC6ffKae-3r6IKJs-Jvw1eaqv9lpxvVt2RXndwN1SVB-nbX3zuVOVV1hRfqqndKTkyynp9tt8D8no3nSez8OHpPk0mD2HGOW_CmAqds8yYMeMGx6AEcq2Bo2JUwUgZveAYjw3NOcScgYGIo1ksAA3NMDdsQC53vStXf7baN7IsfKatVZWuWy9HGDPKedyBbAdmrvbeaSNXriiV20gEuZUrf-XKTq5kciu3S13s69tFqfO_zN5mB1ztgGXxvlwXTktfKms7HOV6vf5X9QNcjILk</recordid><startdate>20020801</startdate><enddate>20020801</enddate><creator>Pai, Rish K</creator><creator>Askew, David</creator><creator>Boom, W. Henry</creator><creator>Harding, Clifford V</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020801</creationdate><title>Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator</title><author>Pai, Rish K ; Askew, David ; Boom, W. Henry ; Harding, Clifford V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-926ed3cff834f180a614ee041a32a07afeb4198f2d409430f0541fbb01f2c1df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Antigen-Presenting Cells - metabolism</topic><topic>B-Lymphocytes - physiology</topic><topic>Dendritic Cells - physiology</topic><topic>Gene Expression Regulation</topic><topic>Genes, MHC Class II</topic><topic>Interferon-gamma - pharmacology</topic><topic>Interleukin-4 - pharmacology</topic><topic>Macrophages - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C3H</topic><topic>Nuclear Proteins</topic><topic>RNA Stability</topic><topic>RNA, Messenger - genetics</topic><topic>Trans-Activators - classification</topic><topic>Trans-Activators - genetics</topic><topic>Trans-Activators - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pai, Rish K</creatorcontrib><creatorcontrib>Askew, David</creatorcontrib><creatorcontrib>Boom, W. Henry</creatorcontrib><creatorcontrib>Harding, Clifford V</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pai, Rish K</au><au>Askew, David</au><au>Boom, W. Henry</au><au>Harding, Clifford V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2002-08-01</date><risdate>2002</risdate><volume>169</volume><issue>3</issue><spage>1326</spage><epage>1333</epage><pages>1326-1333</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>Class II transactivator (CIITA) is necessary for expression of class II MHC (MHC-II) molecules. In mice, CIITA expression is regulated by three promoters (pI, pIII, and pIV), producing types I, III, and IV CIITA. The relative roles of different CIITA types remain unclear. Unstimulated bone marrow-derived macrophages expressed low levels of CIITA mRNA; type I CIITA was nine times more abundant than type IV (type III CIITA was barely detected). Exposure to IFN-gamma (6 h) dramatically increased types I and IV CIITA mRNA to similar absolute levels. Type IV CIITA declined over time, but type I was stable for over 72 h. Thus, the dominant form of CIITA evolved with time during activation by IFN-gamma, and type I CIITA explained prolonged expression of MHC-II by macrophages. mRNA half-life was shorter for type I than type IV CIITA, suggesting that sustained transcription contributed to stable expression of type I CIITA induced by IFN-gamma. Splenic B cells expressed mRNA for type III CIITA but very little for types I or IV. Treatment with IL-4 increased surface expression of MHC-II protein, but mRNA for MHC-II and CIITA (total, I, III, and IV) remained unchanged, suggesting posttranslational regulation. Splenic dendritic cells expressed type I CIITA but little type III or IV; CpG DNA induced their maturation and decreased types I and III CIITA, consistent with decreased MHC-II protein synthesis. CIITA types differ in regulation in various APCs under different stimuli, and the predominant type of CIITA varies at different stages of APC activation.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>12133955</pmid><doi>10.4049/jimmunol.169.3.1326</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1767 |
ispartof | The Journal of immunology (1950), 2002-08, Vol.169 (3), p.1326-1333 |
issn | 0022-1767 1550-6606 |
language | eng |
recordid | cdi_proquest_miscellaneous_71932449 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Animals Antigen-Presenting Cells - metabolism B-Lymphocytes - physiology Dendritic Cells - physiology Gene Expression Regulation Genes, MHC Class II Interferon-gamma - pharmacology Interleukin-4 - pharmacology Macrophages - metabolism Mice Mice, Inbred C3H Nuclear Proteins RNA Stability RNA, Messenger - genetics Trans-Activators - classification Trans-Activators - genetics Trans-Activators - physiology |
title | Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T21%3A40%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20Class%20II%20MHC%20Expression%20in%20APCs:%20Roles%20of%20Types%20I,%20III,%20and%20IV%20Class%20II%20Transactivator&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Pai,%20Rish%20K&rft.date=2002-08-01&rft.volume=169&rft.issue=3&rft.spage=1326&rft.epage=1333&rft.pages=1326-1333&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.169.3.1326&rft_dat=%3Cproquest_cross%3E71932449%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71932449&rft_id=info:pmid/12133955&rfr_iscdi=true |